Evidence map›Paper›PMID 42365315›Full record

ArticleOrphanet journal of rare diseases2026

Management of pregnancy in women with rare multisystemic vascular diseases: a qualitative survey analysis.

Gloria Somalo-Barranco, Alexandra Benachi, Laurence M Boon, Petra Borgards, Janine Dickinson, Freya Droege, Olivier Dupuis, Michael Frank, Guillaume Jondeau, Robert M Kauling and 10 more

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Gloria Somalo-BarrancoHôpital Bichat, VASCERN Coordination Team, Paris, France.
Alexandra BenachiDepartment of Obstetrics and Gynecology, DMU Santé des Femmes et des Nouveau-nés, Assistance Publique Hôpitaux de Paris, Antoine Beclere Hospital, Université Paris-Saclay, Paris, France.
Laurence M BoonDivision of Plastic Surgery, Center for Vascular Anomalies, Saint-Luc University Hospital, UCLouvain, Brussels, Belgium.
Petra BorgardsBundesverband Angeborene Gefäßfehlbildungen e.V., Federal Association of Congenital Vascular Malformation, Mülheim an der Ruhr, Germany.
Janine DickinsonDepartment of Dermatology, Phlebology and Lymphology, Nij Smellinghe Hospital, Drachten, The Netherlands.
Freya DroegeDepartment of Otorhinolaryngology, Essen University Hospital, University of Duisburg-Essen, Essen, Germany.
Olivier DupuisHospices Civils de Lyon, Service de Gynécologie-Obstétrique, Hôpital Lyon-Sud, Pierre-Bénite, France.
Michael FrankDépartement de Génétique, Centre de Référence des Maladies Vasculaires Rares and VASCERN MSA European Reference Centre, AP-HP, Hôpital Européen Georges Pompidou, Paris, France.
Guillaume JondeauDepartment of Cardiology, Centre de référence pour le syndrome de Marfan et apparentés, AP-HP, Université Paris Cité, Hôpital Bichat-Claude Bernard, Paris, France.
Robert M KaulingDepartment of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Diana MarinelloRheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Edit NagyDivision of Valvular and Adult Congenital Heart Disease, Department of Cardiology, Karolinska University Hospital, Theme Heart and Vessels, Stockholm, SE-171 76, Sweden.
Jolien W Roos-HesselinkDepartment of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Meike RybczynskiUniversity Hospital Hamburg-Eppendorf University Heart Centre, Hamburg, Germany.
Pernille Mathiesen TorringDepartment of Clinical Genetics, Odense Universitetshospital, Odense, Denmark.
Carine van der VleutenDepartment of Dermatology, Radboudumc Expertise Center for Haemangiomas and Congenital Vascular Malformations Nijmegen (Hecovan), Radboud University Medical Center, Nijmegen, The Netherlands.
Aline VerstraetenCenter of Medical Genetics, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.
Liesbeth Wildero Van WouweCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Dina ZucchiRheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Julie De BackerCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium. julie.debacker@ugent.be.ORCID http://orcid.org/0000-0001-8878-1507

Funding

European Union within the framework of the EU for Health Programme 101085076
6 · The paper itself

Abstract

backgroundPregnancy in women with rare vascular diseases is highly challenging, as it can be associated with significant maternal and foetal risks, requiring complex and multidisciplinary management. Care across countries remains insufficiently characterized, and both patients and healthcare providers across Europe highlight the need for better structures and organization to support this critical and potentially life-threatening phase.

objectiveTo describe current practices, perspectives, and challenges faced by patients and healthcare professionals in the management of pregnancy in women with rare vascular diseases.

methodsA survey developed by the European Reference Networks (ERN) pregnancy working group was extended with VASCERN-specific questions, resulting in a 13-item questionnaire. The survey was distributed to healthcare providers and patient representatives (ePAGs). Qualitative data from open-ended responses were analysed using an inductive thematic approach.

results36 responses were collected from 145 invited VASCERN members, resulting in a 25% response rate and representing 10 European countries. Most respondents were healthcare providers (83%). 17% were patient representatives. Thematic analysis identified five recurring themes, including the need for coordinated and collaborative multidisciplinary approaches, variability in the practices regarding preconception and genetic counselling, limited access to specialised centres for pregnancy monitoring, and the importance of structured delivery planning and postnatal follow-up.

conclusionsThis survey clearly shows that there are common concerns about pregnancy in women with rare vascular diseases. Improvement actions mainly involve better education and drawing up multidisciplinary care pathways and guidelines that will lead to better access and organisation of care. Initiatives in this direction have already been taken within VASCERN.

Indexed as

Rare DiseasesVascular DiseasesFemaleGenetic CounselingHumansPregnancySurveys and QuestionnairesEuropean Reference NetworkFoetal riskMaternal riskPregnancyVascular disease

Identifiers

PMID42365315
PMCPMC13587322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.